Deepson Bio Co., Ltd., a medical technology company focused on ultrasound-based approaches to dementia treatment, was honored ...

Independence Power Holdings, Inc. ("Independence Power" or the "Company") today announced its transition to a public-reporting company following the successful completion of its business combination ...

Precigen transitioned to a commercial stage company with the US approval of PAPZIMEOS in August 2025, the first-and-only FDA-approved treatment for adults with RRP ...

Trained on 9.7 trillion tokens of evolutionary data, EDEN designs therapeutics from large gene insertion to antimicrobial peptides.

Assimilate Live FX unifies LED wall playback, lighting control, and live compositing in one real-time platform for virtual ...